SecSonar.com

Hims & Hers Health, Inc. (HIMS)

Hims & Hers Health, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Hims & Hers Health, Inc. (HIMS) is a Medical - Equipment & Services company based in US with a market capitalization of $5.9B. Revenue grew 59.0% year-over-year and the company generated $74M in free cash flow. This page tracks HIMS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1.64K employees · IPO Sep 13, 2019

Valuation

Valuation & price

$25.05 · as of May 17, 2026 · -62.1% vs 52w high

50.4

P/E ratio

Latest-FY diluted EPS

10.88

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$66.18$40.82$15.46Jul 25Dec 25Jul 26Jul 7, 25$48.42Jul 9, 25$51.24Jul 11, 25$47.89Jul 15, 25$50.46Jul 17, 25$49.99Jul 21, 25$47.60Jul 23, 25$58.02Jul 25, 25$57.65Jul 29, 25$60.27Jul 31, 25$66.18Aug 4, 25$63.35Aug 6, 25$51.13Aug 11, 25$49.98Aug 13, 25$48.33Aug 15, 25$46.02Aug 19, 25$42.18Aug 21, 25$43.96Aug 25, 25$42.99Aug 27, 25$44.01Aug 29, 25$42.35Sep 3, 25$44.46Sep 5, 25$48.41Sep 9, 25$47.79Sep 11, 25$51.76Sep 16, 25$50.89Sep 18, 25$56.20Sep 22, 25$57.70Sep 24, 25$53.25Sep 26, 25$58.40Sep 30, 25$56.72Oct 2, 25$57.87Oct 6, 25$54.76Oct 8, 25$58.17Oct 10, 25$53.95Oct 14, 25$54.02Oct 16, 25$59.15Oct 21, 25$49.36Oct 23, 25$48.49Oct 27, 25$48.23Oct 29, 25$46.63Oct 31, 25$45.46Nov 4, 25$42.79Nov 6, 25$41.52Nov 10, 25$41.05Nov 12, 25$39.02Nov 14, 25$36.98Nov 18, 25$36.26Nov 20, 25$33.62Nov 25, 25$37.09Nov 28, 25$39.76Dec 2, 25$36.31Dec 4, 25$40.02Dec 8, 25$39.12Dec 10, 25$37.88Dec 12, 25$37.21Dec 16, 25$36.86Dec 18, 25$34.77Dec 22, 25$35.05Dec 24, 25$34.67Dec 29, 25$34.10Jan 2, 26$33.41Jan 6, 26$35.45Jan 8, 26$33.87Jan 12, 26$32.34Jan 14, 26$31.32Jan 16, 26$31.38Jan 21, 26$28.89Jan 23, 26$29.62Jan 27, 26$29.68Jan 29, 26$29.87Feb 2, 26$26.44Feb 4, 26$24.40Feb 9, 26$19.33Feb 11, 26$16.69Feb 13, 26$16.30Feb 18, 26$15.84Feb 20, 26$15.63Feb 24, 26$15.46Feb 26, 26$15.60Mar 2, 26$16.48Mar 4, 26$16.45Mar 6, 26$15.74Mar 10, 26$23.47Mar 12, 26$23.84Mar 17, 26$24.98Mar 19, 26$24.16Mar 23, 26$22.46Mar 25, 26$20.84Mar 27, 26$19.38Mar 31, 26$20.76Apr 2, 26$19.14Apr 7, 26$19.50Apr 9, 26$19.75Apr 13, 26$21.15Apr 15, 26$24.29Apr 17, 26$28.82Apr 22, 26$29.01Apr 24, 26$30.56Apr 28, 26$27.91Apr 30, 26$27.17May 4, 26$27.27May 6, 26$26.88May 8, 26$28.27May 12, 26$25.03May 14, 26$24.24May 18, 26$22.29May 20, 26$23.04May 22, 26$23.75May 28, 26$25.38Jun 1, 26$27.76Jun 3, 26$27.51Jun 5, 26$26.19Jun 9, 26$28.98Jun 11, 26$28.87Jun 15, 26$30.17Jun 17, 26$31.89Jun 22, 26$33.54Jun 24, 26$32.70Jun 26, 26$33.94Jul 2, 26$36.80
$14.5252-week range$66.18
Loading valuation history…

Fundamentals

Key fundamentals

$5.9B

Market cap

59.0%

Revenue growth (YoY)

73.8%

Gross margin

$74M

Free cash flow (USD)

$686.3M

Net debt

4.2%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$82.6MFY 2020$148.8MFY 2021$271.9MFY 2022$526.9MFY 2023$872.0MFY 2024$1.5BFY 2025$2.3B
$82.6M$2.3B

Free cash flow by year

2019 → 2025

FY 2019$-76.7MFY 2020$-6.7MFY 2021$-39.4MFY 2022$-33.8MFY 2023$47.0MFY 2024$198.3MFY 2025$74.0M
-$76.7M$74M

Gross margin by year

2021 → 2025

FY 202175.2%FY 202277.6%FY 202382.0%FY 202479.5%FY 202573.8%
75.2%73.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

10

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventReceivables Purchase AgreementJul 1, 2026Filing
  • Insider sellInsider Sell $619K · 10b5-1 PlanOkupe Oluyemi · Chief Financial Officer · $619.2KJun 23, 2026Filing
  • Insider sellInsider Sell $830KCarroll Patrick Harrison · Chief Medical Officer · $830.4KJun 23, 2026Filing
  • Insider sellInsider Sell $946K · 10b5-1 PlanElshenawy Mohamed · CTO · $946.3KJun 17, 2026Filing
  • Insider sellInsider Sell $371K · 10b5-1 PlanBecklund Irene · PAO · $370.5KJun 17, 2026Filing
  • Insider sellInsider Sell $442K · 10b5-1 PlanChi Michael · Chief Operating Officer · $441.9KJun 17, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 15, 2026Filing
  • 8-K eventDebt RefinancingJun 2, 2026Filing
  • Insider buyInsider Buy $1.2MWELLS DAVID B · Director · $1.2MMay 26, 2026Filing
  • 8-K eventConvertible Notes IssuedMay 21, 2026Filing

Questions

Frequently asked questions

What is Hims & Hers Health, Inc.'s market cap?

Hims & Hers Health, Inc. (HIMS) has a market capitalization of $5.9B.

What is HIMS's P/E ratio?

HIMS trades at a price-to-earnings ratio of 50.4, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is HIMS's price-to-book (P/B) ratio?

HIMS trades at 10.88 times book value per share.

Are insiders buying HIMS stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 10 sells at Hims & Hers Health, Inc. in the last 90 days.

Same arena

Related companies in Medical - Equipment & Services

NVST

Envista Holdings Corp

$3.9B

CON

Concentra Group Holdings Parent, Inc.

$3.2B

BBNX

Beta Bionics, Inc.

$539.2M

PARK

Park Dental Partners, Inc. Common Stock

$37.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.